Cocaine and beta-blockers: should the controversy continue?
Hoffman
Robert S
RS
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D019970:Cocaine-Related Disorders / Q000150:complications* / Q000178:diet therapy*; D000075202:Contraindications; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000188:drug therapy*; D018570:Risk Assessment
D000319:Adrenergic beta-Antagonists